Aelius Biotech announced that it has raised £1.25 million in a round of funding on November 23, 2023. The transaction included participation from new investors North East Venture Fund, a fund co-managed by Mercia Fund Management Ltd. and Mercia Asset Management PLC.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.5 GBX | 0.00% | -3.28% | -2.32% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.32% | 163M | |
+34.57% | 98.94B | |
-5.72% | 93.71B | |
+15.62% | 26.77B | |
-9.52% | 17.46B | |
+3.08% | 14.13B | |
-24.20% | 11.88B | |
+24.21% | 10.24B | |
+18.39% | 9.18B | |
+19.77% | 6.71B |
- Stock Market
- Equities
- MERC Stock
- News Mercia Asset Management PLC
- Aelius Biotech announced that it has received £1.25 million in funding from Mercia Fund Management Ltd., Mercia Asset Management PLC